Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Red Hat is a global leader in open source software solutions for enterprise IT, specializing in hybrid cloud infrastructure, Linux operating systems, containerization (Kubernetes), automation, and middleware. It was acquired by IBM in 2019 for $34 billion and operates as an independent subsidiary.
While not itself a life sciences or biotech company, Red Hat's platforms are widely used by healthcare and pharmaceutical organizations to modernize IT infrastructure, support regulatory compliance (e.g., GxP), enable secure data management and analytics—including AI/ML workloads—and accelerate digital transformation initiatives.
Major pharma companies such as Boehringer Ingelheim have adopted Red Hat OpenShift to speed up digital product delivery while maintaining compliance with industry regulations. Healthcare payers/providers use Red Hat’s hybrid cloud and automation tools for interoperability mandates and security/compliance needs.
The company has more than 19,000 employees worldwide with over 100 offices in more than 40 countries. Its headquarters are located in Raleigh, North Carolina.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Red Hat.